CV Sciences, Inc.
CVSI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $15,705 | $16,004 | $16,205 | $20,048 |
| % Growth | -1.9% | -1.2% | -19.2% | – |
| Cost of Goods Sold | $8,537 | $8,919 | $10,655 | $11,432 |
| Gross Profit | $7,168 | $7,085 | $5,550 | $8,616 |
| % Margin | 45.6% | 44.3% | 34.2% | 43% |
| R&D Expenses | $118 | $151 | $307 | $1,185 |
| G&A Expenses | $3,986 | $6,554 | $3,892 | $13,932 |
| SG&A Expenses | $9,240 | $9,494 | $12,090 | $25,877 |
| Sales & Mktg Exp. | $5,254 | $2,940 | $8,198 | $11,945 |
| Other Operating Expenses | $0 | -$5,920 | $0 | $0 |
| Operating Expenses | $9,358 | $3,725 | $12,397 | $27,062 |
| Operating Income | -$2,190 | $3,360 | -$6,847 | -$18,446 |
| % Margin | -13.9% | 21% | -42.3% | -92% |
| Other Income/Exp. Net | -$212 | -$264 | -$1,414 | $2,805 |
| Pre-Tax Income | -$2,402 | $3,096 | -$8,261 | -$15,641 |
| Tax Expense | -$8 | -$6 | -$47 | -$87 |
| Net Income | -$2,394 | $3,102 | -$8,214 | -$15,554 |
| % Margin | -15.2% | 19.4% | -50.7% | -77.6% |
| EPS | -0.014 | 0.02 | -0.06 | -0.14 |
| % Growth | -167.7% | 133.8% | 57.5% | – |
| EPS Diluted | -0.014 | 0.02 | -0.06 | -0.14 |
| Weighted Avg Shares Out | 175,585 | 153,954 | 138,034 | 107,817 |
| Weighted Avg Shares Out Dil | 175,585 | 153,955 | 138,034 | 107,817 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $212 | $0 | $1,541 | $140 |
| Depreciation & Amortization | $334 | $235 | $1,062 | $1,503 |
| EBITDA | -$1,856 | $3,846 | -$5,658 | -$13,998 |
| % Margin | -11.8% | 24% | -34.9% | -69.8% |